Aspira Women’s Health to Host R&D Day With Updates on the Development of the Company’s Ovarian Cancer and Endometriosis Tests on January 4, 2024

December 19, 2023

https://www.globenewswire.com/news-release/2023/12/19/2798484/0/en/Aspira-Women-s-Health-to-Host-R-D-Day-With-Updates-on-the-Development-of-the-Company-s-Ovarian-Cancer-and-Endometriosis-Tests-on-January-4-2024.html

AUSTIN, Texas, Dec. 19, 2023 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq:AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that it will host a virtual R&D day featuring experts who will present the exciting progress of the company’s product pipeline on January 4, 2024 at 11:00 AM ET. To register, click here.

Read more at globenewswire.com

Related news for (AWH)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.